HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yayoi Inagaki Selected Research

4- (2- (N- (3- pyridylmethyl)carbamoylethenyl)phenoxy)acetate

1/2010TJN-419 improves dextran sulfate sodium-induced colitis via inhibition of interleukin-12 release.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yayoi Inagaki Research Topics

Disease

1Colitis
01/2010
1IGA Glomerulonephritis (IGA Nephropathy)
10/2009
1Sclerosis
10/2009
1Neuroblastoma
11/2008

Drug/Important Bio-Agent (IBA)

14- (2- (N- (3- pyridylmethyl)carbamoylethenyl)phenoxy)acetateIBA
01/2010
1Neutralizing AntibodiesIBA
01/2010
1SolutionsIBA
01/2010
1Dextran SulfateIBA
01/2010
1Interleukin-10 (Interleukin 10)IBA
01/2010
1Interleukin-12 (IL 12)IBA
01/2010
1acteosideIBA
01/2010
1Drinking WaterIBA
01/2010
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2009
1TJN-259IBA
10/2009
1Transforming Growth Factor beta1 (TGF beta 1)IBA
10/2009
1Collagen Type IV (Type IV Collagen)IBA
10/2009
1CarbonIBA
10/2009
1Dihydrotachysterol (AT 10)IBA
10/2009
1EnzymesIBA
10/2009
1Immunoglobulin A (IgA)IBA
10/2009
1ImmunosorbentsIBA
10/2009
1Proteins (Proteins, Gene)FDA Link
10/2009
1Bovine Serum AlbuminIBA
10/2009
1diethyl maleateIBA
11/2008
1Buthionine SulfoximineIBA
11/2008

Therapy/Procedure

2Oral Administration
01/2010 - 10/2009
1Intravenous Injections
01/2010
1Nephrectomy
10/2009